Lanean...
Trastuzumab Administration in Patients with Metastatic Breast Cancer – Experience of a Large University Breast Center
Background: Administered either alone or in combination with various cytostatic, endocrine or targeted therapies, trastuzumab significantly improves the prognosis of patients with HER2-positive breast cancer. As trastuzumab is effective across multiple lines of therapy in the metastatic setting (tre...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Georg Thieme Verlag KG
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069214/ https://ncbi.nlm.nih.gov/pubmed/24976638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0034-1368244 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|